TDM Berhad (2054.KL) stock: key figures, P/E, revenue and dividend
Consumer Staples · Agricultural Products & Services · Malaysia · ISIN MYL2054OO004
TDM Berhad financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 645.65 m MYR | 768.05 m MYR |
| Gross profit | 232.77 m MYR | 272.93 m MYR |
| Operating income | 27.45 m MYR | 52.90 m MYR |
| EBIT | 38.59 m MYR | 74.31 m MYR |
| Net income | 11.22 m MYR | 17.69 m MYR |
| Diluted EPS – continuing operations | 0.01 MYR | 0.01 MYR |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About TDM Berhad
TDM Berhad, an investment holding company, engages in the cultivation of oil palms in Malaysia. The company operates through Plantation and Healthcare segments. It is also involved in the sale of fresh fruit bunches and pineapple fruits; plantation management operations; sale of crude palm oil, palm kernel, bio compost fertilizers, and related products. In addition, the company provides healthcare consultancy and specialist medical centre services. Further, it engages in managing and marketing of various agro commodities; provision of consultancy and management services to specialist medical centres; property development activities; operates specialist medical centre, ambulatory care cenre, and private hospital; and facility management and maintenance, assets management, and real estate businesses. The company was incorporated in 1965 and is headquartered in Kuala Terengganu, Malaysia.
More stocks
- WeConnect (ALWEC.PA)
- Applied BioCode (6598.TW)
- Medivir AB (MVIR.ST)
- SURF AIR MOBILITY INC. (SRFM)
- Kpx Green Chem (083420.KS)
- Codes Combine Co. Ltd (047770.KQ)
- Tainet Communication System (4905.TWO)
- HENNESSY ADVISORS INC (HNNA)
- Jushi Holdings Inc. (JUSH)
- Daejung Chemicals & Metals Co.Ltd (120240.KQ)
- CGRE AG (CGX.DE)
- BioGend Therapeutics Co., Ltd. (6733.TWO)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.